Brief: Sab Biotherapeutics Announces Q1 2024 Financial Results
20/05/2024 22:56
May 20 (Reuters) - SAB Biotherapeutics Inc SABS.O :
* SAB BIOTHERAPEUTICS ANNOUNCES Q1 2024 FINANCIAL RESULTS
AND
PROVIDES COMPANY UPDATES
* QTRLY LOSS PER SHARE $0.43
Source text for Eikon: ID:nGNX8tYWGS
Further company coverage: SABS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SAB Biotherapeutics
See all newsSAB Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
SAB Biotherapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Ferrari, Hawkeye 360, Micron Technology
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies
U.S. STOCKS ON THE MOVE-InspireMD, MiniMed, SoFi Technologies